DR5—FAP bispecific death receptor agonistic antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9481730
APP PUB NO 20120184718A1
SERIAL NO

13498390

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to bispecific antibodies comprising a first antigen binding site specific for a death receptor and a second antigen binding site specific for a second antigen, methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROCHE GLYCART AG A SWISS COMPANYOF WAGISTRASSE 18 SHLIEREN CH-8952

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bruenker, Peter Hittnau, CH 79 1793
Ferrara, Koller Claudia Zug, CH 49 665
Grau, Sandra Birmensdorf, CH 1 63
Herter, Sylvia Regensdorf, CH 16 373
Lampert, Christoph Zurich, CH 1 63
Moessner, Ekkehard Kreuzlingen, CH 194 2920
Umana, Pablo Wollerau, CH 247 5409
Waldhauer, Inja Urdorf, CH 18 184

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 1, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00